Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species-Reference-Cited by-同舟云学术

Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species

Published:2019 Issue:11 Volume:7 Page:4782-4789
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Xu Lei¹²³⁴⁵,Zhang Zhicheng⁵⁶⁷⁸⁴,Ding Yawen⁵⁶⁷⁸⁴,Wang Li⁵⁶⁷⁸⁴,Cheng Yali⁵⁶⁷⁸⁴,Meng Lingtong⁵⁶⁷⁸⁴,Wu Jinhui⁵⁶⁷⁸⁴^ORCID,Yuan Ahu⁵⁶⁷⁸⁴^ORCID,Hu Yiqiao⁵⁶⁷⁸⁴^ORCID,Zhu Yishen¹²³⁴^ORCID

Affiliation:

1. College of Biotechnology and Pharmaceutical Engineering

2. Nanjing Tech University

3. Nanjing 211816

4. China

5. State Key Laboratory of Pharmaceutical Biotechnology

6. Medical School and School of life science

7. Nanjing University

8. Nanjing 210093

Abstract

A biofunctional liposome containing acriflavine (ACF) and doxorubicin (DOX) for reducing the chemotherapy resistance of DOX induced by reactive oxygen species.

Funder

National Basic Research Program of China

National Natural Science Foundation of China

State Key Laboratory of Natural Medicines

Fundamental Research Funds for the Central Universities

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2019/BM/C9BM00590K

Reference36 articles.